🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
14/02/2019 1,4500 USD
15/11/2018 1,3200 USD
16/08/2018 1,3200 USD
16/05/2018 1,3200 USD
14/02/2018 1,3200 USD
16/11/2017 1,1500 USD
15/08/2017 1,1500 USD
15/05/2017 1,1500 USD
13/02/2017 1,1500 USD
14/11/2016 1,0000 USD
15/08/2016 1,0000 USD
13/05/2016 1,0000 USD
11/02/2016 1,0000 USD
12/11/2015 0,7900 USD
13/08/2015 0,7900 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/11/2008 57,58 57,60 54,12 54,93 -1,89% 6,04% 12.537.500
24/11/2008 55,64 56,49 54,99 55,99 +1,99% 2,70% 15.059.600
21/11/2008 51,55 55,08 51,10 54,90 +9,52% 7,72% 19.385.100
20/11/2008 53,63 54,73 50,09 50,13 -6,54% 8,65% 14.172.100
19/11/2008 56,38 56,82 53,55 53,64 -4,79% 5,80% 9.804.900
18/11/2008 55,93 56,77 53,45 56,34 +0,45% 5,94% 12.197.100
17/11/2008 57,14 58,38 55,90 56,09 -3,68% 4,34% 9.900.700
14/11/2008 59,01 60,00 57,89 58,23 -2,30% 3,58% 12.293.400
13/11/2008 55,44 59,62 55,31 59,60 +7,45% 7,77% 13.623.200
12/11/2008 57,53 58,15 55,20 55,47 -5,07% 5,13% 9.322.600
11/11/2008 58,22 59,31 57,61 58,43 -0,60% 2,92% 8.427.600
10/11/2008 60,74 60,90 57,55 58,78 -0,15% 5,52% 7.846.800
07/11/2008 57,49 58,88 56,40 58,87 +4,08% 4,31% 10.007.000
06/11/2008 59,09 60,47 56,44 56,56 -4,81% 6,82% 16.848.400
05/11/2008 59,77 60,57 59,34 59,42 -1,90% 2,06% 10.646.800
04/11/2008 62,26 62,46 59,62 60,57 -1,59% 4,56% 11.450.800
03/11/2008 60,47 61,84 60,21 61,55 +2,77% 2,70% 10.330.500
31/10/2008 60,61 61,56 59,17 59,89 -1,06% 3,94% 11.082.000
30/10/2008 60,47 60,98 59,36 60,53 +2,80% 2,68% 9.008.400
29/10/2008 59,82 60,99 58,57 58,88 -1,87% 4,05% 14.680.600
28/10/2008 55,98 60,00 55,65 60,00 +9,61% 7,77% 17.302.700
27/10/2008 56,08 57,61 54,45 54,74 -4,25% 5,63% 11.593.200
24/10/2008 52,64 58,45 52,55 57,17 +2,92% 11,21% 15.758.400
23/10/2008 53,15 57,85 51,59 55,55 +11,77% 11,78% 22.943.900
22/10/2008 51,38 52,21 49,40 49,70 -5,03% 5,47% 10.422.600
21/10/2008 52,44 54,79 51,95 52,33 -1,91% 5,42% 8.633.500
20/10/2008 50,55 53,45 50,33 53,35 +6,30% 6,17% 10.236.500
17/10/2008 49,10 53,87 49,00 50,19 -1,20% 9,92% 13.615.400
16/10/2008 47,91 50,89 46,63 50,80 +6,37% 8,89% 15.247.700
15/10/2008 51,97 52,27 47,25 47,76 -7,46% 9,66% 12.997.500